December 11-13, 2018


The Tumor Targeted Lymphocytes Summit is the only dedicated meeting focused on identifying key strategies to automate GMP manufacturing to grow, culture and expand TIL and CTL cells for commercial grade therapies.

Partnering with the Tumor Targeted Lymphocytes meeting will ensure you capitalize on the market early, cement your position as an industry leader and support the rate of discovery and clinical development of novel gene editing and combination trials to create unique and IP driven therapies you can take to market.

Why sponsor? 

Showcase Expertise and Build Credibility – Take this opportunity to demonstrate your clinical expertise to an exclusive community of decision makers in search of support

Build Relationships With Senior Level Decision Makers – Network with all of the leading members of the autoimmune community in one room over three days. Use this platform to interact and hear first-hand the challenges that industry leaders face

Drive Brand to Forefront of Mind – As pharma, biotech and academia seek out-of-house expertise, are you front of mind? Take this chance to benefit from increased exposure, differentiate your company from competitors and ensure you identify as a leader of the autoimmune space

Tailored Opportunities include: 

Speaking Opportunities – position yourself as the thought leader in your space or educate your market

Panel Moderator – curate and drive the disruptive conversation alongside some of the brightest minds in the fields

Roundtable Leader – get interactive with our community through a more informal channel

Workshop Leader – lead a more focused and in-depth discussion with an exclusive and tailored made audience

Exclusive VIP Hosting – sometimes relaxing together is as important as working together, why not buy the room a drink!

Exhibiting – have your flag in the ground and let the onsite community know where  to meet you

For more information, please contact Jonathan Kilby-Phillips


Phone: +1 212 537 5898